Johnny John
Chief Tech/Sci/R&D Officer at DELCATH SYSTEMS, INC.
Net worth: 10 022 $ as of 2024-03-30
Profile
Johnny John is currently working as the Senior VP-Clinical Development & Medical Affairs at Delcath Systems, Inc. Prior to his current position, he worked at inVentiv Health, Inc. as Operations-Clinical Trials from 2004 to 2012.
Dr. John completed his undergraduate and doctorate degrees at Mangalore University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DELCATH SYSTEMS, INC.
0.01% | 2023-06-11 | 2,101 ( 0.01% ) | 10 022 $ | 2024-03-30 |
Johnny John active positions
| Companies | Position | Start |
|---|---|---|
| DELCATH SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 2012-03-18 |
Former positions of Johnny John
| Companies | Position | End |
|---|---|---|
inVentiv Health, Inc.
 inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Corporate Officer/Principal | 2011-12-31 |
Training of Johnny John
| Mangalore University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DELCATH SYSTEMS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
- Stock Market
- Insiders
- Johnny John
